PI
ABBV icon

PFG Investments’s AbbVie ABBV Stock Holding History

PFG Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.78M Buy
38,855
+3,348
+9% +$720K 0.38% 49
2026
Q1 		$7.72M Sell
35,507
-717
-2% -$159K 0.36% 53
2025
Q4 		$8.28M Buy
36,224
+4,517
+14% +$1.03M 0.39% 44
2025
Q3 		$7.34M Buy
31,707
+333
+1% +$67.8K 0.38% 48
2025
Q2 		$5.82M Buy
31,374
+77
+0.2% +$14.3K 0.34% 57
2025
Q1 		$6.56M Sell
31,297
-776
-2% -$151K 0.42% 42
2024
Q4 		$5.7M Sell
32,073
-660
-2% -$121K 0.35% 54
2024
Q3 		$6.46M Sell
32,733
-612
-2% -$114K 0.42% 41
2024
Q2 		$5.72M Buy
33,345
+1,290
+4% +$214K 0.41% 43
2024
Q1 		$5.84M Buy
32,055
+16,989
+113% +$2.93M 0.35% 57
2023
Q4 		$2.33M Buy
15,066
+1,110
+8% +$162K 0.43% 40
2023
Q3 		$2.08M Sell
13,956
-502
-3% -$73.7K 0.39% 47
2023
Q2 		$1.95M Buy
14,458
+1,536
+12% +$225K 0.35% 60
2023
Q1 		$2.06M Buy
+12,922
New +$1.98M 0.42% 50

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PFG Investments's ABBV Position: Q2 2026 in Review

PFG Investments increased its AbbVie (ABBV) stake by 9.4% in Q2 2026, buying an estimated $720K and bringing the position to 38,855 shares worth $9.78M. The position accounts for 0.38% of the portfolio, ranked #49.

PFG Investments first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • PFG Investments held 38,855 shares of AbbVie worth $9.78M as of Q2 2026.
  • PFG Investments bought 3,348 AbbVie shares in Q2 2026, an estimated $720K.
  • AbbVie made up 0.38% of PFG Investments's portfolio in Q2 2026, its #49 holding.
  • PFG Investments first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.